Anjali Saqi

6.7k total citations · 3 hit papers
131 papers, 3.6k citations indexed

About

Anjali Saqi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Anjali Saqi has authored 131 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Pulmonary and Respiratory Medicine, 50 papers in Oncology and 35 papers in Surgery. Recurrent topics in Anjali Saqi's work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Diagnosis and Treatment (25 papers) and Lung Cancer Research Studies (22 papers). Anjali Saqi is often cited by papers focused on Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Diagnosis and Treatment (25 papers) and Lung Cancer Research Studies (22 papers). Anjali Saqi collaborates with scholars based in United States, Japan and United Kingdom. Anjali Saqi's co-authors include John P. Crapanzano, Catherine A. Shu, William A. Bulman, Joshua Sonett, Naiyer A. Rizvi, Diane Hamele‐Bena, Mark Stoopler, Govind Bhagat, Jonas J. Heymann and Fabrizio Remotti and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Anjali Saqi

121 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial

2020 425 citations Catherine A. Shu, Justin F. Gainor et al. profile →
Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

2018 342 citations Gregory P. Kalemkerian, Navneet Narula et al. Journal of Clinical Oncology profile →
RUNX2 promotes fibrosis via an alveolar-to-pathological fibroblast transition

2025 17 citations Yinshan Fang, Sanny S.W. Chung et al. profile →

Peers

Anjali Saqi

PRM

ONCOL

SURGE

EPIDE

Marie Christine Aubry United States

Akira Iyoda Japan

Jhingook Kim South Korea

Yukihiro Imai Japan

Michael A. den Bakker Netherlands

Mitual Amin United States

J. Guigay France

Yung-Chie Lee Taiwan

Hiroyasu Yokomise Japan

Bruno Märkl Germany

Marie Christine Aubry United States

Anjali Saqi

1.4k ×0.7

PRM

1.3k ×0.8

ONCOL

451 ×0.7

SURGE

375 ×0.6

EPIDE

368 ×0.7

Citations per year, relative to Anjali Saqi Anjali Saqi (= 1×) peers Marie Christine Aubry

Countries citing papers authored by Anjali Saqi

Since Specialization

Citations

This map shows the geographic impact of Anjali Saqi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjali Saqi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjali Saqi more than expected).

Fields of papers citing papers by Anjali Saqi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anjali Saqi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjali Saqi. The network helps show where Anjali Saqi may publish in the future.

Co-authorship network of co-authors of Anjali Saqi

This figure shows the co-authorship network connecting the top 25 collaborators of Anjali Saqi. A scholar is included among the top collaborators of Anjali Saqi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anjali Saqi. Anjali Saqi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

May, Michael, Jonathan Lee, Xin Ma, et al.. (2025). The impact of eligibility criteria on Kirsten rat sarcoma G12C inhibitor trials in patients with non–small cell lung cancer. JNCI Journal of the National Cancer Institute. 118(1). 49–57.

Schrode, Nadine, et al.. (2025). Human respiratory airway progenitors derived from pluripotent cells generate alveolar epithelial cells and model pulmonary fibrosis. Nature Biotechnology. 44(3). 394–405. 4 indexed citations

Roy‐Chowdhuri, Sinchita, Christine N. Booth, Jonas J. Heymann, et al.. (2025). Optimizing cytology and small biopsy specimen processing for ancillary studies: recommendations from the American Society of Cytopathology taskforce. Journal of the American Society of Cytopathology. 14(5). 285–308.

Davis‐Porada, Julia, et al.. (2025). Lung tissue–resident memory T cells optimize protection by IL-10 regulation of innate immunity. The Journal of Experimental Medicine. 223(1).

Jurkiewicz, Magdalena, Raymond Yeh, Catherine A. Shu, et al.. (2025). Challenges in Amplicon-Based DNA NGS Identification of MET Exon 14 Skipping Events in Non-Small Cell Lung Cancers. SHILAP Revista de lepidopterología. 6(1). 5–5.

Keating, Claire, et al.. (2024). Unusual presentation of ROS1 rearranged metastatic non-small cell lung cancer. Respiratory Medicine Case Reports. 51. 102091–102091.

Heymann, Jonas J., Cristiana M. Pineda, Joshua Menke, et al.. (2024). Tools, techniques, and challenges in preparing cytology specimens for ancillary studies: results of the ASC Optimizing Cytology and Small Biopsy Specimen Processing for Ancillary Studies task force survey. Journal of the American Society of Cytopathology. 14(1). 55–63. 1 indexed citations

Shi, Peiguo, Wanwei Zhang, Sanny S.W. Chung, et al.. (2024). Sympathetic Neurons Promote Small Cell Lung Cancer through the β2-Adrenergic Receptor. Cancer Discovery. 15(3). 616–632. 9 indexed citations

Qiu, Baiyu, Fereshteh Zandkarimi, Anjali Saqi, et al.. (2024). Fatal COVID-19 pulmonary disease involves ferroptosis. Nature Communications. 15(1). 3816–3816. 31 indexed citations

10.

Lin, Tiffany, et al.. (2024). Lung nodule malignancy classification with associated pulmonary fibrosis using 3D attention-gated convolutional network with CT scans. Journal of Translational Medicine. 22(1). 51–51. 12 indexed citations

11.

Henick, Brian S., Peter D. Koch, Justin F. Gainor, et al.. (2024). Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings. Journal for ImmunoTherapy of Cancer. 12(12). e009301–e009301. 4 indexed citations

12.

Postler, Thomas S., Anqi Wang, Francesco Brundu, et al.. (2023). A pan-cancer analysis implicates human NKIRAS1 as a tumor-suppressor gene. Proceedings of the National Academy of Sciences. 120(46). e2312595120–e2312595120. 3 indexed citations

13.

Washburn, Robert S., Radomir Kratchmarov, Shana M. Coley, et al.. (2022). Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy. Cancer Immunology Research. 11(2). 164–170. 13 indexed citations

14.

Chait, Michael, Amy Ku, Pranay Dogra, et al.. (2022). Immune and epithelial determinants of age-related risk and alveolar injury in fatal COVID-19. JCI Insight. 7(11). 6 indexed citations

15.

Michele, Simona De, Helen Remotti, Armando Del Portillo, et al.. (2020). SATB2 in Neoplasms of Lung, Pancreatobiliary, and Gastrointestinal Origins. American Journal of Clinical Pathology. 155(1). 124–132. 14 indexed citations

16.

Michele, Simona De, Yu Sun, Igor Katsyv, et al.. (2020). Forty Postmortem Examinations in COVID-19 Patients. American Journal of Clinical Pathology. 154(6). 748–760. 67 indexed citations

17.

Shaish, Hiram, Firas S. Ahmed, David J. Lederer, et al.. (2020). Deep Learning of Computed Tomography Virtual Wedge Resection for Prediction of Histologic Usual Interstitial Pneumonitis. Annals of the American Thoracic Society. 18(1). 51–59. 30 indexed citations

18.

Lagana, Stephen M., Satoru Kudose, Alina C. Iuga, et al.. (2020). Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data. Modern Pathology. 33(11). 2147–2155. 167 indexed citations

19.

Kalemkerian, Gregory P., Navneet Narula, Erin B. Kennedy, et al.. (2018). Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update. Journal of Clinical Oncology. 36(9). 911–919. 342 indexed citations breakdown →

20.

Saqi, Anjali, Martin W. Oster, & Madeline Vazquez. (2005). Metastatic mammary carcinomas with endocrine features: Potential diagnostic pitfalls. Diagnostic Cytopathology. 33(1). 49–53. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact